Examine FDA, ICH, and USP Approaches to the Control of Impurities
Choose and Evaluate Tools for Impurities Identification

Plus: In-Depth Extractables and Leachables Coverage:
·New Approaches Toward the Identification of Extractables and Leachables
·Toxicology and Risk Assessment Considerations
·Extractable and Leachable Considerations for Photoinitiators

Special in-depth session:
USP Approaches and Initiatives for Impurities Behnam Davani, Ph.D., United States Pharmacopeia (USP)